AI can drive cars and play chess better than the masters, but can it really aid medicinal chemistry?
On the virtues of automated quantitative structure–activity relationship: the new kid on the block
PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation
Natural antioxidants in hybrids for the treatment of neurodegenerative diseases: a successful strategy?
Perspective: the benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions
Research article: enhancing anticancer activity through the combination of bioreducing agents and triterpenes